Could a single dose of meloxicam beat ibuprofen for Post-Surgery pain?
NCT ID NCT07200544
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a single dose of meloxicam (a different anti-inflammatory) can control pain better than the usual ibuprofen after Mohs surgery for skin cancer. About 300 adults will be split into three groups, each getting a different pain medicine routine. They will rate their pain and satisfaction through surveys right after surgery and the next day.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN, ACUTE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Oklahoma Health Sciences Center
RECRUITINGOklahoma City, Oklahoma, 73104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can your genes predict your melanoma risk?
- A UV photo and a cheek swab may be the keys to stopping sunburn before it starts
- Deep breaths may slash post-surgery pain and anxiety — a trial puts it to the test
- Night shift workers' skin may struggle to fix sun damage, study suggests
- What makes skin cancer patients happy after surgery?
- Alpha radiation seeds target tumors from the inside